Session Details

This session will explore strategies for de-escalating axillary surgery and regional nodal radiation after neoadjuvant chemotherapy in clinically node-positive patients, and how these approaches will influence adjuvant therapy decisions in HR+/HER2- breast cancer.

Presentation numberCT2-01

De-escalation of axillary surgery after NAC in clinically node positive patients

Giacomo Montagna, Memorial Sloan Kettering Cancer Center, New York, NY

Presentation numberCT2-02

De-escalation of regional nodal radiation after NAC in clinically node positive patients

Lori Pierce, University of Michigan, Ann Arbor, MI

Presentation numberCT2-03

Adjuvant therapy decisions in HR+HER2- breast cancer in the era of axillary de-escalation

Sherry Shen, Memorial Sloan Kettering Cancer Center, New York, NY